-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 23, local time, the U.
The U.
The statement said that monabiravir is a prescription drug, and patients must take it as soon as possible after the diagnosis of new coronary pneumonia, start taking it within 5 days after the onset of symptoms of new coronary pneumonia, and use it continuously for no more than 5 days
Monabiravir should not be used in people under the age of 18 because the drug may affect bone and cartilage growth, the statement said
Cavazzoni, director of the FDA's Center for Drug Evaluation and Research, said that as new mutant strains continue to emerge, it is critical to expand the available options for treating new coronavirus infections in the United States through emergency use authorization, while continuing to evaluate the safety of these options.
The U.
